Klacid Saft Forte

Clarithromycin, the active ingredient in Klacid Saft Forte, is a macrolide antibiotic presented as an oral solution for oral administration. It is used to treat a variety of bacterial infections, including community‑acquired pneumonia, acute sinusitis, skin infections and Helicobacter pylori‑related conditions, in both adult and pediatric patients as directed by a prescriber.

GNH USA supplies Klacid Saft Forte as a licensed, GDP‑compliant international pharmaceutical supplier, providing the product to hospitals, pharmacies and clinics worldwide, ensuring consistent availability and regulatory compliance.

Clarithromycin is a macrolide antibiotic indicated for several bacterial infections affecting the respiratory, ENT, skin and gastrointestinal systems. - Community‑acquired pneumonia: eradicates the causative bacteria, leading to clinical improvement and resolution of pulmonary infection. - Acute bacterial sinusitis: reduces sinus mucosal inflammation by eliminating the infecting organisms. - Skin and soft tissue infections: clears bacterial skin lesions and prevents spread. - Helicobacter pylori eradication (in combination therapy): contributes to bacterial eradication as part of triple‑therapy regimens. - Streptococcal pharyngitis: treats the infection, relieving sore throat and preventing complications.

Clarithromycin may cause a range of adverse reactions, which are categorized by frequency and severity.

Common Side Effects: - Nausea, vomiting or abdominal discomfort. - Altered taste sensation or metallic taste. - Headache. - Mild skin rash or itching.

Serious or Rare Side Effects: - Severe allergic reactions such as anaphylaxis or Stevens‑Johnson syndrome. - QT interval prolongation leading to cardiac arrhythmias. - Clostridioides difficile‑associated diarrhea, which can be life‑threatening.

When prescribing Klacid Saft Forte, clinicians should consider several safety aspects. - Renal or hepatic impairment: dose may need adjustment and monitoring. - Drug interactions: review concomitant medications, especially those affecting QT interval or CYP3A4. - Pregnancy and lactation: use only if benefit outweighs risk (Category B). - Elderly patients: monitor for cardiac effects and drug accumulation. - Allergy to macrolides: contraindicated. - Store at ambient temperature below 25°C: keep in original container, protect from moisture and light.

Clarithromycin interacts with several medicines; awareness of interaction severity guides clinical decisions.

Major Interactions (Avoid): - Co‑administration with other macrolides (e.g., erythromycin, azithromycin): additive toxicity. - Cisapride or domperidone: increased risk of serious cardiac arrhythmias. - HIV protease inhibitors such as ritonavir: markedly increased clarithromycin plasma levels.

Moderate Interactions (Monitor Closely): - Statins (simvastatin, lovastatin): heightened risk of myopathy. - Warfarin: enhanced anticoagulant effect; monitor INR. - Theophylline: increased serum concentrations; monitor for toxicity.